Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Evaluation of the effectiveness of Clobex® Spray, 0.05% when used as monotherapy or add-on
therapy to existing systemic or topical anti-psoriatic agents.